Novel drug inhibits MLL leukemia progression in mice [PreClinical]
1. Mice harboring tumors with translocations of the mixed lineage leukemia (MLL) gene showed decreased tumor size and increased survival ...
1. Mice harboring tumors with translocations of the mixed lineage leukemia (MLL) gene showed decreased tumor size and increased survival ...
Originally published by Harvard Health. What Is It? Acute myeloid leukemia (AML) is a type of leukemia. It is also called ...
In this section, we highlight the key high-impact studies, updates, and analyses published in medicine during the past week. Goal-Directed ...
1. Ibrutinib was superior to ofatumumab in a head-to-head trial in patients who have failed initial therapy for chronic lymphoid ...
Image: PD In this section, we will highlight the key high-impact studies, updates, and analyses published in medicine during the ...
Image: PD 1. Idelalisib plus rituximab improved progression-free survival in patients with relapsing CLL compared to rituximab plus placebo. This ...
Image: PD In this section, we will highlight the key high-impact studies, updates, and analyses published in medicine during the ...
Image: PD 1. IV busulfan combined with cyclophosphamide (BuCy) is associated with better leukemia-free and overall survival in acute myeloid ...
Image: PD Normal Mammogram 1. New technological developments for five different cancers found not to impact mortality trends favorably 2. ...
Image: PD 1. Patients with newly-diagnosed low-to-intermediate risk acute promyelocytic leukemia (APL) treated with all-trans retinoic acid (ATRA) plus arsenic ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.